Methylated -tubulin antibodies recognize a new microtubule modification on mitotic microtubules.
Academic Article
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
Posttranslational modifications (PTMs) on microtubules differentiate these cytoskeletal elements for a variety of cellular functions. We recently identified SETD2 as a dual-function histone and microtubule methyltransferase, and methylation as a new microtubule PTM that occurs on lysine 40 of -tubulin, which is trimethylated (-TubK40me3) by SETD2. In the course of these studies, we generated polyclonal (-TubK40me3 pAb) and monoclonal (-TubK40me3 mAb) antibodies to a methylated -tubulin peptide (GQMPSD-Kme3-TIGGGDC). Here, we characterize these antibodies, and the specific mono-, di- or tri-methylated lysine residues they recognize. While both the pAb and mAb antibodies recognized lysines methylated by SETD2 on microtubules and histones, the clone 18 mAb was more specific for methylated microtubules, with little cross-reactivity for methylated histones. The clone 18 mAb recognized specific subsets of microtubules during mitosis and cytokinesis, and lacked the chromatin staining seen by immunocytochemistry with the pAb. Western blot analysis using these antibodies revealed that methylated -tubulin migrated faster than unmethylated -tubulin, suggesting methylation may be a signal for additional processing of -tubulin and/or microtubules. As the first reagents that specifically recognize methylated -tubulin, these antibodies are a valuable tool for studying this new modification of the cytoskeleton, and the function of methylated microtubules.
